|
|
|
CALGARY, May 22 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has successfully transferred cGMP production for REOLYSIN(R) at the 40-litre batch size to SAFC Pharma(TM), a Division of Sigma-Aldrich Corporation.
Full Coverage:
Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
CALGARY, May 23 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced it has been granted Canadian Patent 2,360,833 entitled "Reovirus for the Treatment of Cellular Proliferative Disorders." The claims describe the use of one or more recombinant...
Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
CALGARY, May 23 /CNW/ - "This patent provides the Company with additional patent protection for the use of reovirus compositions for cancers and other cellular proliferative disorders in Canada," said Mary Ann Dillahunty, Vice President of Intellectual Property for...
Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
CALGARY, May 23 Oncolytics-Biotech CALGARY, May 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced it has been granted Canadian Patent 2,360,833 entitled "Reovirus for the Treatment of Cellular Proliferative Disorders." The claims describe...
Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
CALGARY, May 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced it has been granted Canadian Patent 2,360,833 entitled "Reovirus for the Treatment of Cellular Proliferative Disorders." The claims describe the use of one or more recombinant...
Oncolytics Transfers 40 L cGMP Manufacturing Process for Anticancer Agent to SAFC Pharma
GEN News Highlights Oncolytics Biotech reports successfully transferred cGMP production for its cancer drug candidate at the 40-liter batch size to SAFC Pharma. The compound Reolysin is in multiple clinical programs in different cancer types. Yields at the 40-litre scale should provide sufficient...
The Maybach Review: Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for...
MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. On Thursday, May 22, 2008, we have added Oncolytics Biotech Inc. (NASDAQ: ONCY) to the list of potential prospects. ***Please visit our site to find genuine analyst reports on numerous...
Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R)
CALGARY, May 22 /CNW/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has successfully transferred cGMP production for REOLYSIN(R) at the 40-litre batch size to SAFC Pharma(TM), a Division of Sigma-Aldrich Corporation. "Manufacturing at a commercial scale...
Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R)
Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R) CALGARY, May 22 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has successfully transferred cGMP production for REOLYSIN(R) at the 40-litre batch...
Oncolytics granted new patent
Oncolytics Biotech has received US patent for claims that cover pharmaceutical compositions which comprise various recombinant reoviruses. Mary Dillahunty, vice president of intellectual property at Oncolytics, said: "This patent provides the company with additional patent protection for reovirus...
Oncolytics Biotech announces issuance of 27th U.S. patent
Oncolytics Biotech Inc. today announced that it has been granted U.S. Patent 7,374,752 entitled "Reovirus for the Treatment of Cellular Proliferative Disorders." The claims cover pharmaceutical compositions which comprise various recombinant reoviruses. "This patent provides the Company with...
International Editions
English - US | English - UK | Deutsch | Française | Español | Português | Italiano | Česká | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese)Copyright © 2008 Newstin a.s. All rights reserved. 4.2.5,fe-web-4.2.5;commons-4.2.1;api-4.2.1;fe-4.2.3, 10.10.1.29